TNF-α pretreatment prevents subsequent activation of cultured brain cells with TNF-α and hypoxia via ceramide

American Journal of Physiology - Cell Physiology

Volumn 276, Issue 5 45-5, 1999, Pages

  Ginis, Irene ^a,b   Schweizer, Ulrich ^a   Brenner, Michael ^a   Liu, Jie ^a   Azzam, Nabil ^a   Spatz, Maria ^a   Hallenbeck, John M ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Astrocytes; Brain endothelial cells; Ceramide; Intercellular adhesion molecule 1; Ischemic tolerance; Tumor necrosis factor

Indexed keywords

CERAMIDE; FUMONISIN B1; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN CAPILLARY; BRAIN CELL; BRAIN HYPOXIA; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; RNA ANALYSIS;

ANIMALIA;

EID: 0033017265     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1999.276.5.c1171     Document Type: Article

References (11)

1. Arvin, B., L. F. Neville, F. C. Barone, and G. Z. Feuerstein. The role of inflammation and cytokines in brain injury. Neurosci. Biobehav. Rev. 20: 445-452, 1996.
2. Ballestas, M. E., and E. N. Benveniste. Interleukin-1β- and tumor necrosis factor-α-mediated regulation of ICAM-1 gene expression in astrocytes requires protein kinase C activity. Glia 14: 267-278, 1995.
3. Roland, M. P., and L. A. O'Neill. Ceramide activates NF-κB by inducing the processing of p105. J. Biol. Chem. 273: 15494-15500, 1998.
4. Carlson, S. L., D. J. Belting, C. A. Kiani, K. M. Abell, and J. P. McGillis. Catecholamines decrease lymphocyte adhesion to cytokine-activated endothelial cells. Brain Behav. Immun. 10: 55-67, 1996.
5. Casaccia-Bonnefil, P., L. Aibel, and M. V. Chao. Central glial and neuronal populations display differential sensitivity to ceramide-dependent cell death. J. Neurosci. Res. 43: 382-389, 1996.
6. Chen, J., and R. Simon. Ischemic tolerance in brain. Neurology 48: 306-311, 1997.
7. Chopp, M., Y. Li, N. Jiang, R. L. Zhang, and J. Prostak. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J. Cereb. Blood Flow Metab. 16: 578-584, 1996.
8. Dawson, D. A., D. Martin, and J. M. Hallenbeck. Inhibition of tumor necrosis factor-α reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci. Lett. 218: 41-44, 1996.
9. Dbaibo, G. S., D. K. Perry, C. J. Gamard, R. Platt, G. G. Poirier, L. M. Obeid, and Y. A. Hannun. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J. Exp. Med. 185: 481-490, 1997.
10. Dobrowsky, R. T., C. Kamibayashi, M. C. Mumby, and Y. A. Hannun. Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268: 15523-15530, 1993.
11. D'Souza, S., K. Alinauskas, E. McCrea, C. Goodyer, and J. P. Antel. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immunemediated injury. J. Neurosci. 15: 7293-7300, 1995.